Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary A Stacy

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Hospital Pharmacy|May 15, 2024
The Use of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Pharmacist's PerspectiveZachary A Stacy, Sara K Richter
Therapeutic Advances in Cardiovascular Disease|August 8, 2018
Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populationsZachary A Stacy, Sara K Richter
Journal of Managed Care Pharmacy : JMCP|November 23, 2005
Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patientsPaul P Dobesh, Zachary A Stacy
Pharmacotherapy|April 29, 2009
Pharmacologic therapy for intermittent claudicationPaul P Dobesh, Zachary A Stacy, Emily L Persson
Pharmacotherapy|June 29, 2006
Cardiovascular risks of cyclooxygenase inhibitionZachary A Stacy, Paul P Dobesh, Toby C Trujillo
Pharmacotherapy|May 21, 2013
Utilization of coagulation assays in clinical therapeuticsGoldie L Peters, P Benjamin Erwin, Matthew K Pitlick, et al.
Hospital Pharmacy|May 15, 2024
Conception of a Personalized Medication Adherence Discharge Kit for RivaroxabanGretchen M Stern, Jamie M Pitlick, Zachary A Stacy, et al.
Pharmacotherapy|November 13, 2004
Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery diseasePaul P Dobesh, Zachary A Stacy, Alexander J Ansara, et al.
Cardiology and Therapy|March 4, 2016
Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous ThromboembolismZachary A Stacy, William B Call, Aaron P Hartmann, et al.
SAGE Open Medicine|August 8, 2017
Comparison of hospital length of stay in patients treated with non-vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolismCatherine A Saint, Michelle R Castelli, Andrew J Crannage, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Hospital Pharmacy|May 15, 2024
The Use of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Pharmacist's PerspectiveZachary A Stacy, Sara K Richter
Therapeutic Advances in Cardiovascular Disease|August 8, 2018
Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populationsZachary A Stacy, Sara K Richter
Journal of Managed Care Pharmacy : JMCP|November 23, 2005
Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patientsPaul P Dobesh, Zachary A Stacy
Pharmacotherapy|April 29, 2009
Pharmacologic therapy for intermittent claudicationPaul P Dobesh, Zachary A Stacy, Emily L Persson
Pharmacotherapy|June 29, 2006
Cardiovascular risks of cyclooxygenase inhibitionZachary A Stacy, Paul P Dobesh, Toby C Trujillo
Pharmacotherapy|May 21, 2013
Utilization of coagulation assays in clinical therapeuticsGoldie L Peters, P Benjamin Erwin, Matthew K Pitlick, et al.
Hospital Pharmacy|May 15, 2024
Conception of a Personalized Medication Adherence Discharge Kit for RivaroxabanGretchen M Stern, Jamie M Pitlick, Zachary A Stacy, et al.
Pharmacotherapy|November 13, 2004
Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery diseasePaul P Dobesh, Zachary A Stacy, Alexander J Ansara, et al.
Cardiology and Therapy|March 4, 2016
Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous ThromboembolismZachary A Stacy, William B Call, Aaron P Hartmann, et al.
SAGE Open Medicine|August 8, 2017
Comparison of hospital length of stay in patients treated with non-vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolismCatherine A Saint, Michelle R Castelli, Andrew J Crannage, et al.
Pageof 2